Assessing the Impact of Chronic Obstructive Pulmonary Disease on Severity of Silent Myocardial Ischemia in Patients with Arterial Hypertension
https://doi.org/10.58838/2075-1230-2024-102-3-12-17
Abstract
The objective: to evaluate the effect of chronic obstructive pulmonary disease on the severity of silent myocardial ischemia in patients with arterial hypertension.
Subjects and Methods. Examinations and follow-up of 194 COPD patients who were undergoing outpatient follow-up and treatment were analyzed. Those patients suffered from COPD with concurrent arterial hypertension or isolated arterial hypertension.
Results. Holter ECG monitoring should be done in all COPD patients regardless of severity of the disease and presence of comorbid conditions. This is due to the high prevalence of silent myocardial ischemia in such patients.
About the Authors
T. V. Tayutina
Rostov State Medical University, Russian Ministry of Health
Russian Federation
Russian Federation
Tatiana V. Tayutina, candidate of Medical Sciences, Associate Professor of Therapy Department with Training in Polyclinic Therapy
29 Nakhichevansky Lane, Rostov-on-Don 344022
Phone: + 7 (928) 226-71-85
D. A. Kudlay
I.M. Sechenov First Moscow State Medical University (Sechenov University), Russian Ministry of Health; Lomonosov Moscow State University; Immunology Research Institute by the Russian Federal Medical Biological Agency
Russian Federation
Russian Federation
Dmitry A. Kudlay, Correspondent Member of RAS, Doctor of Medical Sciences, Professor of Pharmacology Department of Pharmaceutical Science Institute; Professor of Department of Pharmacognosy and Industrial Pharmacy, Faculty of Fundamental Medicine; Leading Researcher of Laboratory of Personalized Medicine and Molecular Immunology no. 71
29 Nakhichevansky Lane, Rostov-on-Don 344022; 8 Bd. 2, Trubetskaya St., Moscow 119991
Phone: + 7 (499) 617-10-27; Phone: +7 (499) 248-05-53
L. A. Shovkun
Rostov State Medical University, Russian Ministry of Health
Russian Federation
Russian Federation
Lyudmila A. Shovkun, Doctor of Medical Sciences, Professor, Head of Tuberculosis Department
29 Nakhichevansky Lane, Rostov-on-Don 344022
Phone: + 7 (928) 188-60-82
N. Yu. Nikolenko
Moscow Research and Clinical Center for Tuberculosis Control, Moscow Health Department
Russian Federation
Russian Federation
Nikolay Yu. Nikolenko, Candidate of Pharmaceutical Sciences, Researcher of Scientific Clinical Department
10 Stromynka St., Moscow 107014
Phone: + 7 (499) 268-00-05
E. D. Kampos
Rostov State Medical University, Russian Ministry of Health
Russian Federation
Russian Federation
Elena D. Kampos, Candidate of Medical Sciences, Associate Professor of Tuberculosis Department
29 Nakhichevansky Lane, Rostov-on-Don 344022
Phone: + 7(906) 429-20-36
References
1. Kuznetsov A.N., Grigorieva N.Yu., Ilyushina T.P., Mayorova M.V. Is there a relationship between bronchial asthma and arterial hypertension? Terapiya, 2017, vol. 1, no. 11, pp. 60-64. (In Russ.)
2. Nevzorova V.A., Zakharchuk N.V., Brodskaya T.A. et al. Evaluation of cardiovascular risk in chronic obstructive pulmonary disease using spirometry indices. Siberian Medical Review, 2018, vol. 110, no. 2, pp. 18-24. (In Russ.) https://doi.org/10.20333/2500136-2018-2-18-24
3. Oganov R.G., Denisov I.N., Simanenkov V.I. et al. Comorbid pathology in clinical practice (guidelines). Kardiovaskulyarnaya Terapiya i Profilaktika, 2017, vol. 17, no. 6, pp. 5-56. (In Russ.)
4. Poliklinicheskaya Terapiya. Uchebnik. [Polyclinic therapy. Handbook]. D.I. Davydkin, Yu.V. Schukin, eds., 2nd ed., suppl. and amend., Moscow, GEOTAR-Media Publ., 2020, 840 p.
5. Khasanov A.Kh., Bakirov B.A., Davletshin R.A. et al. Impact of endothelial dysfunction on gender-specific vascular and neurocognitive heterogeneity in multifocal atherosclerosis in elderly patients. Russian Journal of Preventive Medicine, 2019, vol. 22, no. 4, pp. 129-137. (In Russ.)
6. Khasanov A.Kh., Bakirov B.A., Davletshin R.A. et al. Clinical features of comorbid cluster and premorbidly manifestations in patients with high vascular risk in the middle age category with the presence of multifocal atherosclerosis. Kardiologiia, 2019, vol. 59, no. 7, pp. 31-36. (In Russ.)
7. Chazova I.E., Nevzorova V.A., Ambatiello L.G. et al. Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease. Systemic Hypertension, 2020, vol. 17, no. 3, pp. 7-34. (In Russ.) https://doi.org/10.26442/2075082X.2020.3.200294
8. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2019. Available: https://goldcopd.org/ Accessed Dec 01, 2023
Review
For citations:
Tayutina T.V., Kudlay D.A., Shovkun L.A., Nikolenko N.Yu., Kampos E.D. Assessing the Impact of Chronic Obstructive Pulmonary Disease on Severity of Silent Myocardial Ischemia in Patients with Arterial Hypertension. Tuberculosis and Lung Diseases. 2024;102(3):12-17. (In Russ.) https://doi.org/10.58838/2075-1230-2024-102-3-12-17
Views:
351
Email this article 